Literature DB >> 3956882

Magnesium deficiency in IDDM related to level of glycosylated hemoglobin.

A Sjögren, C H Florén, A Nilsson.   

Abstract

Magnesium and potassium were analyzed in plasma, erythrocytes, and urine collected during 24 h and in muscle biopsies from 25 subjects with insulin-dependent, type I diabetes mellitus (IDDM). Magnesium was also measured in mononuclear cells. The results were compared with those of 28 healthy controls, and were also correlated with the degree of diabetic control as estimated by analysis of the level of glycosylated hemoglobin (HbA1c). Subjects with IDDM had significantly lower muscle (P less than 0.01) and plasma (P less than 0.001) concentrations of magnesium compared with those of healthy controls. The HbA1c levels correlated significantly with the concentrations of magnesium in muscle (r = -0.62, P less than 0.001), plasma (r = -0.62, P less than 0.001), and mononuclear cells (r = -0.47, P less than 0.05). The results indicate that some patients with IDDM have lowered contents of magnesium in striated muscular and/or plasma, and that those parameters are dependent on the degree of diabetic control.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956882     DOI: 10.2337/diab.35.4.459

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Effect of Magnesium pre-treatment on alloxan induced hyperglycemia in rats.

Authors:  A I Abayomi; E O Adewoye; S B Olaleye; A T Salami
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

2.  Magnesium status and digoxin toxicity.

Authors:  I S Young; E M Goh; U H McKillop; C F Stanford; D P Nicholls; E R Trimble
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

3.  Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus.

Authors:  F Corica; R Ientile; A Allegra; G Romano; F Cangemi; A Di Benedetto; M Buemi; D Cucinotta; D Ceruso
Journal:  Biol Trace Elem Res       Date:  1996-01       Impact factor: 3.738

4.  Calcium homeostasis in prepubertal diabetic children.

Authors:  A Verrotti; A Blasetti; S Tumini; F Chiarelli; G Morgese
Journal:  Acta Diabetol Lat       Date:  1988 Apr-Jun

5.  Improvement of cardiac ventricular function by magnesium treatment in chronic streptozotocin-induced diabetic rat heart.

Authors:  Hamida Aboalgasm; Morea Petersen; Asfree Gwanyanya
Journal:  Cardiovasc J Afr       Date:  2020-12-10       Impact factor: 1.167

6.  Lower incidence of hypo-magnesemia in surgical intensive care unit patients in 2011 versus 2001.

Authors:  John T Denny; Enrique Pantin; Antonio Chiricolo; James Tse; Thomas Jan; Mohammad Chaudhry; Sylviana Barsoum; Angela M Denny; Denes Papp; Sharon L Morgan
Journal:  J Clin Med Res       Date:  2015-02-09

Review 7.  The Role of Magnesium in the Pathogenesis and Treatment of Glaucoma.

Authors:  Feyzahan Ekici; Şafak Korkmaz; Emine Esra Karaca; Sabahattin Sül; Hasan Ali Tufan; Bahri Aydın; Ergin Dileköz
Journal:  Int Sch Res Notices       Date:  2014-10-13

8.  Cellular Trace Element Changes in Type 1 Diabetes Patients.

Authors:  Vahap Uğurlu; Çiğdem Binay; Enver Şimşek; Cengiz Bal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

9.  Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile.

Authors:  Doaa Shahbah; Amr Abo El Naga; Tamer Hassan; Marwa Zakaria; Mohamed Beshir; Salah Al Morshedy; Mohamed Abdalhady; Ezzat Kamel; Doaa Abdel Rahman; Lamiaa Kamel; May Abdelkader
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia.

Authors:  Doaaa Shahbah; Tamer Hassan; Saeed Morsy; Hosam El Saadany; Manar Fathy; Ashgan Al-Ghobashy; Nahla Elsamad; Ahmed Emam; Ahmed Elhewala; Boshra Ibrahim; Sherief El Gebaly; Hany El Sayed; Hanan Ahmed
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.